Notably, in survivors, the regulatory cytokine axis response positively correlated with the IgM-S levels, while the IgG-S and IgG-RBD—the key antibodies associated with COVID-19 survival—correlated strongly with the TGF-β1 response. This evidence concerns the gene TGFB1 and COVID-19.